Genetically Targeted Dipeptidyl Peptidase-4 Inhibitor Use in a Patient with a Novel Mutation of MODY type 4

Genetically Targeted Dipeptidyl Peptidase-4 Inhibitor Use in a Patient with a Novel Mutation of MODY type 4

Show other versions (1)

Bibliographic Details
Main Authors:	Christian Mangrum, Eric Rush, Vijay Shivaswamy
Format:	Article
Language:	English
Published:	SAGE Publishing 2015-10-01
Series:	Clinical Medicine Insights: Endocrinology and Diabetes
Online Access:	http://www.la-press.com/genetically-targeted-dipeptidyl-peptidase-4-inhibitor-use-in-a-patient-article-a5161

Similar Items

Genetically Targeted Dipeptidyl Peptidase-4 Inhibitor Use in a Patient with a Novel Mutation of MODY type 4
by: Christian Mangrum, et al.
Published: (2015-01-01)

Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions
by: Awadhesh Kumar Singh
Published: (2014-01-01)

Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
by: A S Ametov, et al.
Published: (2013-01-01)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
by: Na-Hyung Kim, et al.
Published: (2014-01-01)

Dipeptidyl peptidase 4 inhibitors in modern domestic practice
by: A. S. Ametov, et al.
Published: (2020-05-01)

Dipeptidyl peptidase-4 inhibitors use in clinical practice
by: Tatiana B. Morgunova, et al.
Published: (2019-04-01)

Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
by: Shoombuatong W, et al.
Published: (2015-08-01)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
by: Kaisa Tasanen, et al.
Published: (2019-06-01)

Health economic evaluation of dipeptidyl peptidase-4 inhibitors
by: Vishvas Garg
Published: (2011-01-01)

Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging
by: Fen Cao, et al.
Published: (2021-08-01)

The role of dipeptidyl peptidase - 4 inhibitors in diabetic kidney disease
by: Usha ePanchapakesan, et al.
Published: (2015-08-01)

Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes
by: Bernd Richter, et al.
Published: (2008-08-01)

UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4
by: T. V. Romanova, et al.
Published: (2018-06-01)

Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
by: Yun-Mi Jang, et al.
Published: (2011-04-01)

A review on cardiovascular outcome studies of dipeptidyl peptidase-4 inhibitors
by: Maneesha Khalse, et al.
Published: (2018-01-01)

Bullous pemphigoid with dipeptidyl peptidase‐4 inhibitors: Clinical features and pathophysiology
by: Takaaki Murakami, et al.
Published: (2019-09-01)

DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
by: Erna Kristin
Published: (2016-12-01)

Dipeptidyl Peptidase-4 Is a Target Protein of Epigallocatechin-3-Gallate
by: Huimin Hou, et al.
Published: (2020-01-01)

Regulation of dipeptidyl peptidase-4 inhibitor on Lipopolysaccharide induced inflammation and activation of macrophages
by: CHEN, JING-MIN, et al.
Published: (2019)

Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4
by: E V Oskola, et al.
Published: (2013-09-01)

Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor – A case report
by: S Karthik, et al.
Published: (2019-01-01)

The Potential of some Plant Extracts as Radical Scavengers and Dipeptidyl Peptidase-4 Inhibitors
by: Malik et al.
Published: (2019-03-01)

Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Metabolism and the Possible Underlying Mechanisms
by: Yinqiu Yang, et al.
Published: (2017-07-01)

C-Peptide Levels Predict the Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Therapy
by: Sevin Demir, et al.
Published: (2016-01-01)

Dipeptidyl Peptidase-4 Inhibitor-associated Bullous Pemphigoid: Recurrence with Epitope Spreading
by: Hiroyuki Takama, et al.
Published: (2018-08-01)

Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors
by: Jong-Mi Seong, et al.
Published: (2021-09-01)

Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
by: Jung Min Lee, et al.
Published: (2019-10-01)

Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
by: Natasha A Trzaskalski, et al.
Published: (2020-03-01)

Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
by: Das SS, et al.
Published: (2014-05-01)

Research on Bone Fracture Risk with Dipeptidyl peptidase-4 inhibitors in Patients with Diabetes Mellitus
by: Yu-Ting Sung, et al.
Published: (2017)

Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression
by: Eugene Yu-Chuan Kang, et al.
Published: (2021-06-01)

Vipidia is a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
by: T. B. Morgunova, et al.
Published: (2015-12-01)

Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
by: Yayoi Nishida, et al.
Published: (2020-04-01)

Review of the cardiovascular safety of dipeptidyl peptidase-4 inhibitors and the clinical relevance of the CAROLINA trial
by: Marile Santamarina, et al.
Published: (2019-03-01)

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin
by: Capuano A, et al.
Published: (2013-09-01)

Time to exacerbation of heart failure is longer in Malaysian population on dipeptidyl peptidase-4 inhibitor
by: J Hasan, et al.
Published: (2017-01-01)

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
by: Hiroki Esaki, et al.
Published: (2017-11-01)

Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?
by: Yong-ho Lee
Published: (2015-06-01)

Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy
by: Mary Elizabeth Cox, et al.
Published: (2010-01-01)

Association between Dipeptidyl Peptidase-4 Inhibitors and Allergic Rhinitis in Asian Patients with Diabetes
by: Hsin-Hung Chen, et al.
Published: (2019-04-01)

Cannot write session to /tmp/vufind_sessions/sess_airudcti1r61f4t3mo2gpgqtrp